Literature DB >> 21056489

Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis.

Shi-Xiong Liang1, Xiao-Bo Huang, Xiao-Dong Zhu, Wei-Dong Zhang, Lin Cai, Hua-Zhong Huang, Ye-Fei Li, Long Chen, Meng-Zhong Liu.   

Abstract

PURPOSE: Radiation-induced liver disease (RILD) is the most severe complication in liver cancer treatment. The aim of this study was to identify dosimetric predictors for RILD in primary liver carcinoma (PLC) patients with Child-Pugh Grade A cirrhosis after hypofractionated conformal radiotherapy (CRT). METHODS AND MATERIALS: A total of 114 eligible patients (mean age 45 years old) were enrolled and treated. The mean gross tumor volume (GTV) was (378.3±308.1) cm(3). A median dose of 53 Gy was delivered to the PLC by hypofractionated CRT (three fractions/week) with a median fraction size of 4.6 Gy (range: 4-6 Gy).
RESULTS: Patients were followed up for 1-79 months (median 19 months) after the completion of irradiation. RILD was diagnosed in nine (7.9%) patients. Univariate analyses revealed that GTV and the percentage of normal liver volume receiving more than 5-40 Gy irradiations (V(5-40)) were related to the risk of developing RILD. Multivariate analyses demonstrated that only GTV and V(20) were independent predictors. Using V(20) as the predictor for RILD, the accuracy, sensitivity, and specificity was 76.3%, 88.9%, and 75.2%, respectively.
CONCLUSIONS: Our data suggest that V(20) is the unique significant dosimetric predictor for RILD risks in PLC patients with Child-Pugh Grade A cirrhosis after hypofractionated CRT.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056489     DOI: 10.1016/j.radonc.2010.10.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  27 in total

1.  Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.

Authors:  Hee Chul Park; Jeong Il Yu; Jason Chia-Hsien Cheng; Zhao Chong Zeng; Ji Hong Hong; Michael Lian Chek Wang; Mi Sook Kim; Kwan Hwa Chi; Po-Ching Liang; Rheun-Chuan Lee; Wan-Yee Lau; Kwang Hyub Han; Pierce Kah-Hoe Chow; Jinsil Seong
Journal:  Liver Cancer       Date:  2016-05-03       Impact factor: 11.740

Review 2.  Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jeong Il Yu; Hee Chul Park
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

3.  Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models.

Authors:  Matthew H Stenmark; Yue Cao; Hesheng Wang; Andrew Jackson; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence; Mary Feng
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

4.  Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma.

Authors:  Seok Hyun Son; Chul Seung Kay; Jin Ho Song; Sea-Won Lee; Byung Ock Choi; Young Nam Kang; Jeong Won Jang; Seung Kew Yoon; Hong Seok Jang
Journal:  Radiat Oncol       Date:  2013-01-09       Impact factor: 3.481

5.  A dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinoma.

Authors:  Ryo Ogino; Masako Hosono; Kentaro Ishii; Daisaku Tatsumi; Shinichi Tsutsumi; Yoshitaka Miki; Yutaka Masuoka; Yasuhiko Shimatani; Yukio Miki
Journal:  J Radiat Res       Date:  2013-02-14       Impact factor: 2.724

6.  A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.

Authors:  Dong Chen; Renben Wang; Xiangjiao Meng; Tonghai Liu; Hongjiang Yan; Rui Feng; Shangang Liu; Shumei Jiang; Xiaoqing Xu; Kunli Zhu; Xue Dou
Journal:  Radiat Oncol       Date:  2014-02-06       Impact factor: 3.481

7.  Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma.

Authors:  Young Il Kim; Hee Chul Park; Do Hoon Lim; Hyo Jung Park; Sang Won Kang; Su Yeon Park; Jin Sung Kim; Youngyih Han; Seung Woon Paik
Journal:  Radiat Oncol J       Date:  2012-12-31

8.  Hepatic dysfunction after radiotherapy for primary gastric lymphoma.

Authors:  Hidekazu Tanaka; Shinya Hayashi; Kazuhiro Ohtakara; Hiroaki Hoshi
Journal:  J Radiat Res       Date:  2012-07-31       Impact factor: 2.724

9.  Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma.

Authors:  Seok Hyun Son; Hong Seok Jang; Hyochun Lee; Byung Ock Choi; Young Nam Kang; Jeong Won Jang; Seung Kew Yoon; Chul Seung Kay
Journal:  Radiat Oncol       Date:  2013-03-15       Impact factor: 3.481

10.  Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma.

Authors:  Seok Hyun Son; Hong Seok Jang; In-Young Jo; Byung Ock Choi; Jeong Won Jang; Seung Kew Yoon; Chul Seung Kay
Journal:  Radiat Oncol       Date:  2014-04-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.